Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer's Experts

Press releases

Dec 8, 2025

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer's Disease

Press releases

Dec 1, 2025

Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025

Press releases

Nov 24, 2025

Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of AD

Press releases

Jul 8, 2025

Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders

Press releases

Jun 18, 2025

Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

News

Apr 22, 2025

Circular Genomics Strengthens Scientific Advisory Board with Addition of Alzheimer's Disease Expert

Press releases

Mar 19, 2025

Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease

Press releases

Mar 17, 2025

5 Promising RNA Biotech Companies To Watch in 2025

News

Mar 13, 2025

Podcast: "Revolutionizing Depression Treatment with Dr. Nikolaos Mellios"

News

Jan 14, 2025

Podcast: "How Do I Know My Antidepressants Are Working?"

News

Jan 14, 2025

Precision Psychiatry: A Paradigm Shift for Mental Healthcare

News

Nov 12, 2024

Bringing precision medicine to psychiatry: circular RNAs as a window into the brain

News

Nov 5, 2024

Circular Genomics launches antidepressant response test

News

Sep 17, 2024

Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers

Press releases

Sep 16, 2024